🎗️ Tomorrow is #WorldLungCancerDay. A recent Lung Cancer publication shows that the EORTC QLQ-C30 and QLQ-LC29 capture many common patient-reported symptomatic adverse events in #NSCLC, supporting the use of PROs alongside clinician-reported assessments. www.eortc.org/publications/ @qol.eortc.org

A timely look at how patient-reported outcomes (PROs) have shaped cancer research and care, and where the field is heading next. 👇 #QualityofLife #CancerResearch

EORTC Quality of Life Group (QLG)@qol.eortc.org · 6d ago

🗣️ Giving patients a voice in cancer care. From the EORTC QLQ-C30 to digital and adaptive patient-reported outcome (PRO) measures, this paper in EJC highlights the impact of the @eortc.org #QualityofLife Group and its vision for the future. 🔗 qol.eortc.org/eortc-qlg-ou... #GivingVoice2Patients

📄 New publication from the @eortc.org #QualityofLife Group. The new EORTC QLQ‑VU34 questionnaire was developed to better capture the impact of vulva cancer and its treatment on patients' quality of life. 🔗 www.eortc.org/publications/ #CancerResearch #GivingVoice2Patients

A new review in the European Journal of Cancer, led by EORTC, analysed 53 randomised pragmatic oncology trials. 🔬 Surrogate endpoints remained the most common primary endpoints, ahead of overall survival and quality of life. 🔗Read more: www.eortc.org/publications/ #CancerResearch

Final results from the EORTC SPECTA Arcagen study and EURACAN highlight the value of molecular profiling in rare cancers. 🔬 69.4% of patients had actionable alterations, identifying personalised treatment opportunities and supporting access to precision medicine. 🔗 www.eortc.org/blog/2026/07...

📢 The #EANO–EORTC CNS Metastasis Meeting 2027 marks a new chapter in #CNS metastasis research, bringing together researchers and clinicians to advance science and improve patient care. Abstract submission opens 31 Aug 2026. #CNSmetastasis2027 @eortc.org 👉 Learn more: www.eano.eu/eanomeetings...

EORTC is launching BRACE, a new clinical study evaluating radiotherapy as a bladder-preserving alternative for high-risk, non-muscle-invasive #BladderCancer after BCG treatment failure. Thanks to @komoptegenkanker.bsky.social, Rising Tide and the study team for supporting this research.

📢 Save the date Join us in Brussels on 26–27 February 2027 for the EANO–EORTC CNS Metastasis Meeting. 🗓️ Abstract submission opens: 31 August 2026 👉 Read more: www.eortc.org/event/eortc-... #EORTC #EANO #NeuroOncology #CNSMetastases #CancerResearch

EORTC-EANO CNS Metastasis Meeting 2027 - EORTC

We are pleased to announce the upcoming EANO-EORTC CNS Metastasis Meeting, taking place on 26–27 February 2027 in Brussels, Belgium.

eortc.org

EANO@eanoassociation.bsky.social · 4w ago

📢 The #EANO–EORTC CNS Metastasis Meeting 2027 marks a new chapter in #CNS metastasis research, bringing together researchers and clinicians to advance science and improve patient care. Abstract submission opens 31 Aug 2026. #CNSmetastasis2027 @eortc.org 👉 Learn more: www.eano.eu/eanomeetings...

New publication on peritoneal mesothelioma highlights the value of molecular profiling for identifying potential treatment opportunities in this rare cancer. Congrats to Julien Péron, Nazim Benzerdjeb, Jean-Yves Blay, Marie Morfouace & collaborators. 🔗 Read more: spectaplatform.org/2026/07/15/p...

Adolescents & young adults with cancer face unique challenges. Recent expert commentary by Sam Sodergren et al. in @hospitalhealthcare.bsky.social explores the importance of age-appropriate HRQOL assessment & the role of @eortc.org QLQ-AYA30. 🔗 hospitalhealthcare.com/specialisms/... #QualityofLife

📢 Are you passionate about improving quality of life in cancer care? Join EORTC’s QoL Department and help develop an AI-powered solution that captures patients’ experiences and advances patient-centred cancer research. 🔗Apply here: www.eortc.org/job/fellowsh... 📍 Brussels (hybrid) | Apply now

How can Europe maximise the value of health data while protecting innovation? EORTC shares key recommendations for the successful implementation of #EHDS. ⬇️ 🔗 https://www.eortc.org/blog/2026/07/08/eortc-position-ehds/ European Commission #EHDS #EuropeanHealthDataSpace #CancerResearch

Have you ever read a cancer clinical trial consent form? We’d love your feedback 💬 We’re working to improve patient information and invite patients, caregivers & advocates to share their experience. 🕒 Takes ~15 min 🔒 Fully anonymous 👉 https://www.surveymonkey.com/r/EORTC_PISIC_project

🚨 Abstract submission deadline tomorrow! Last chance to submit your research for #ENAsymp26. Don't miss out on the opportunity to help shape the future of cancer therapeutics. ⏰ Deadline: 8 July 👉 https://event.eortc.org/ena2026/abstract/ American Association for Cancer Research (AACR)

🎯Key takeaways from the EORTC #ASPIRE study presented at #ESMOGI26. ASPIRE is one of the largest analyses comparing PD-L1 CPS & TAP scoring in gastroesophageal adenocarcinoma (GEA). Congratulations to Dr Petrillo & all ASPIRE collaborators. @myesmo.bsky.social #EORTCgastrointestinal 👇

Part three of ECRF 50th anniversary story is live. In 2014, Count Diego du Monceau became Chair, marking a new chapter for the EORTC Cancer Research Fund and strengthening its support for independent cancer research. 👉 https://ow.ly/8oXx50ZjNR6 #ECRF50 #CancerResearch #Oncology

🔬 Only a few days left to submit your abstract for #ENAsymp26. 📅 Deadline: 8 July 2026 👉 Submit now: https://event.eortc.org/ena2026/abstract/ American Association for Cancer Research (AACR) The National Cancer Institute #CancerResearch #Oncology

📍We are in Munich for #ESMOGI26. Come and visit us at our booth #34 on the first floor. Don’t miss the Rapid Oral Session at 09:35 on Saturday where Angelica Petrillo will be presenting the #ASPIRE study results. @myesmo.bsky.social #ClinicalTrials #CancerResearch #Oncology

We are pleased to have contributed to this discussion on the EU Biotech Act. Our recently published position paper proposes targeted refinements to enhance clarity, reduce administrative burden, & better enable patient-centred clinical trials. Read more: www.eortc.org/blog/2026/06...

Cancer Patients Europe@cancerpatientseu.bsky.social · last mo.

Thank you to everyone who joined our webinar “How can the EU Biotech Act accelerate early access for patients through an improved clinical trials framework?”, as part of CPE's 2026 Policy Webinar Series. A special thanks also to our speakers! #CancerPatients #ClinicalTrials #EUBiotechAct

A closer look 👇 The @eortc.org Annual Report 2025 highlights progress across the network—including the #QualityofLife Group’s work to keep quality of life at the heart of cancer research 🌻 Take a look at our contribution & explore the full report: www.eortc.org/annual-report/ #GivingVoice2Patients

📢 New @thelancetoncol.bsky.social publication insights from EORTC trial 22922/10925 focusing on an unplanned subset analysis of patients with node-negative (pN0) breast cancer with centrally or medially located tumours. 🎥 Watch video & learn more: www.eortc.org/blog/2026/05... #EORTCbreast

At #6WCCL, Pablo L. Ortiz-Romero presents a poster on EORTC 1820 MOGAT. Interim data show sequential mogamulizumab + TSEB is tolerable in early-stage MF. Final results will assess progression-free outcomes. 👏 Congrats to all contributors. #6WCCL #EORTCcutanouslymphoma

50 years of EORTC Cancer Research Fund (ECRF) HRH Princess Dina Mired shares why independent cancer research matters, and her hope that no cancer patient is left behind. 🔗 Full video: www.eortcresearchfund.org/anniversary/ #ECRF50 #CancerResearch #ClinicalTrials

At EORTC, meaningful patient involvement starts with education. Our Patient Days equip patients with the knowledge and confidence to engage in clinical research, not only as participants, but as partners shaping study design and priorities. Discover more: www.eortc.org/annual-report/ #EORTCimpact

📢 Fellowship opportunity in Biostatistics (2026–2027) Gain hands-on experience in statistical analysis, clinical study methodology & scientific publications within an international research network. 👉 Apply here: www.eortc.org/job/fellowsh... #CancerResearch

EORTC welcomes the EU Biotech Act as a step forward for clinical research in Europe. We propose targeted refinements to better support efficient, patient-centred trials. 🔗 Read more: https://www.eortc.org/blog/2026/06/24/biotech-act-position-paper/

📢 Don't forget to register to #ENAsymp26! Tomorrow is your last chance to secure the Early Registration Rate. ⚠️ Don't miss out! 👉 https://event.eortc.org/ena2026/registration/ American Association for Cancer Research (AACR) The National Cancer Institute #CancerResearch #Oncology #ClinicalTrials

🎤 Today at the 10th UK PROMs Research Conference Louis Fox from the @eortc.org #QualityofLife Group is presenting an international effort to improve HRQoL measurement for patients receiving Immune Checkpoint Inhibitors (ICIs). 👉 sheffield.ac.uk/smph/events/... #CancerResearch #GivingVoice2Patients

Part two of the ECRF 50th anniversary story is live. From Sir Christopher Mallaby's leadership to lasting partnerships, discover the next chapter in the ECRF journey. 👉 https://www.eortcresearchfund.org/2026/06/19/building-on-strong-foundations/ #ECRF50 #CancerResearch #Oncology

#MCCRWorkshop Class of 2026. An inspiring week bringing together dedicated fellows and generous faculty—sharing ideas and building connections that outlast the workshop. Since 1999, MCCR has been a space where protocols take shape, careers grow, and clinical cancer research moves forward.